| Skeletal fractures negatively correlate with overall survival in men with prostate cancer MG Oefelein, V Ricchiuti, W Conrad, MI Resnick The Journal of urology 168 (3), 1005-1007, 2002 | 451 | 2002 |
| Reassessment of the definition of castrate levels of testosterone: implications for clinical decision making MG Oefelein, A Feng, MJ Scolieri, D Ricchiutti, MI Resnick Urology 56 (6), 1021-1024, 2000 | 380 | 2000 |
| Testosterone replacement therapy after primary treatment for prostate cancer PK Agarwal, MG Oefelein The Journal of urology 173 (2), 533-536, 2005 | 280 | 2005 |
| Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer MG Oefelein, V Ricchuiti, W Conrad, A Seftel, D Bodner, H Goldman, ... The Journal of urology 166 (5), 1724-1728, 2001 | 254 | 2001 |
| Primary breast augmentation clinical trial outcomes stratified by surgical incision, anatomical placement and implant device type JD Namnoum, J Largent, HM Kaplan, MG Oefelein, MH Brown Journal of Plastic, Reconstructive & Aesthetic Surgery 66 (9), 1165-1172, 2013 | 235 | 2013 |
| Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues. IY Kim, HJ Ahn, DJ Zelner, JW Shaw, S Lang, M Kato, MG Oefelein, ... Clinical cancer research: an official journal of the American Association …, 1996 | 232 | 1996 |
| Failure to achieve castrate levels of testosterone during luteinizing hormone releasing hormone agonist therapy: the case for monitoring serum testosterone and a treatment … MG Oefelein, R CORNUM The Journal of urology 164 (3 Part 1), 726-729, 2000 | 228 | 2000 |
| Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder D Staskin, G Kay, C Tannenbaum, HB Goldman, K Bhashi, J Ling, ... International journal of clinical practice 64 (9), 1294-1300, 2010 | 159 | 2010 |
| Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients. IY Kim, HJ Ahn, S Lang, MG Oefelein, R Oyasu, JM Kozlowski, C Lee Clinical cancer research: an official journal of the American Association …, 1998 | 156 | 1998 |
| A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin GL Drusano, SL Preston, M Van Guilder, D North, M Gombert, M Oefelein, ... Antimicrobial agents and chemotherapy 44 (8), 2046-2051, 2000 | 144 | 2000 |
| Managing late periprosthetic fluid collections (seroma) in patients with breast implants: a consensus panel recommendation and review of the literature B Bengtson, GS Brody, MH Brown, C Glicksman, D Hammond, H Kaplan, ... Plastic and reconstructive surgery 128 (1), 1-7, 2011 | 127 | 2011 |
| The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies MG Oefelein, N Smith, M Carter, D Dalton, A Schaeffer The Journal of urology 154 (6), 2128-2131, 1995 | 125 | 1995 |
| Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder MB Chancellor, DR Staskin, GG Kay, BW Sandage, MG Oefelein, ... Drugs & aging 29, 259-273, 2012 | 119 | 2012 |
| Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy MG Oefelein, K Kaul, B Herz, MD Blum, JM Holland, TC Keeler, WA Cook, ... The Journal of urology 155 (1), 238-242, 1996 | 119 | 1996 |
| Anaplastic large T-cell lymphoma and breast implants: a review of the literature M Jewell, SL Spear, J Largent, MG Oefelein, WP Adams Jr Plastic and reconstructive surgery 128 (3), 651-661, 2011 | 109 | 2011 |
| Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: implications for dosing … MG OEFELEIN The Journal of urology 160 (5), 1685-1688, 1998 | 107 | 1998 |
| Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era MG Oefelein, PK Agarwal, MI Resnick The Journal of urology 171 (4), 1525-1528, 2004 | 103 | 2004 |
| National practice patterns for immediate postoperative instillation of chemotherapy in nonmuscle invasive bladder cancer MS Cookson, SS Chang, MG Oefelein, JR Gallagher, B Schwartz, K Heap The Journal of urology 187 (5), 1571-1576, 2012 | 88 | 2012 |
| The accuracy of the increased prostate specific antigen level (greater than or equal to 20 ng./ml.) in predicting prostate cancer: is biopsy always required? RE Gerstenbluth, AD Seftel, N Hampel, MG Oefelein, MI Resnick The Journal of urology 168 (5), 1990-1993, 2002 | 83 | 2002 |
| Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate MG Oefelein, ND Smith, JT Grayhack, AJ Schaeffer, KT McVary The Journal of urology 158 (4), 1460-1465, 1997 | 82 | 1997 |
Dr. Hilton Kaplan, MBBCh FCSSA PhDSenior Medical Director, Avanos MedicalVerified email at avanos.com
